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Abstract
Two populations of CD4 single positive (SP) thymocytes were found In transgenic mice bearing
class l-restricted Mls-1" reactive (V^8.1) TCR genes in the absence of the restriction element.
£Q3high CQ4 sp cells were deleted In the presence of Mls-1 • and were cortisone resistant,
whereas CD310" CD4 SP cells were not deleted In the presence of Mls-1* and were cortisone
sensitive. Intravenous transfer of CD310" CD4 SP cells into nude mice resulted in significant
peripheral expansion of these cells with apparent upregulation of CD3. These data Indicate that
CD3*0" CD4 SP thymocytes represent an Intermediate stage In the transition from CDS101" double
positive (DP) to CD3hlflh SP thymocytes and raise the possibility that these cells may have
undergone positive but not negative selection events (at least to Mls-11). Furthermore the fact
that CD3hlflh DP thymocytes were also deleted by Mls-1" in these mice suggests strongly that
sensitivity to Mls-1 • deletion Is dependent upon stage of thymic maturation (as revealed by TCR
density) rather than CD4/CD8 phenotype.
Introduction
During T cell development in the murine thymus the T cell
repertoire is both negatively selected to delete potentially self
reactive clones (1 -3 ) and positively selected to allow antigen
recognition in the context of self MHC molecules in the periphery
(4-6). In order to study the developmental sequence of such
T cell repertoire selection, we have produced transgenic mice
carrying the TCR o& chains V^-JJWl (aT) and VfiAOJ^A
(/Sj) specific for lymphocytic chonomeningitis virus (LCMV)
presented in the context of H-2Db (7). Positive selection of the
transgenic TCR and the resultant skewing of thymocytes and
peripheral T cells to the CD8 lineage in these mice had previously
been shown to be dependent on the presence of the H-2b
molecule (7,8). Furthermore, negative selection via clonal deletion
was found to occur at an early stage of intrathymic development
when the transgenic TCR was expressed in H-2b LCMV carrier
mice (7,8). Collectively these data are compatible with other
recent studies of repertoire selection employing MHC restricted
transgenic TCR specific for antigens such as H-Y and H-2 Ld
(reviewed in ref. 9).
In the present study, we have extended our analysis of these
TCR transgenic mice by crossing them on a BALB/c (H-2d, i.e.
non-selective) background in the presence or absence of the
minor lymphocyte stimulatory antigen Mls-1a. Since the flj
encodes a Mls-1a reactive V^S.i domain (10,11), such mice
should allow analysis of the developmental sequence of Mls-1a
specific clonal deletion in the absence of a dominant positive
selection. We show here that CD4+CD8+ 'double positive' (DP)
as well as CD4+CD8" or CD4"CD8+ 'single positive' (SP)
thymocytes expressing high levels of /3T are deleted by Mls-1a.
In addition we document the existence of a cortisone sensitive
subset of CD4 SP thymocytes expressing low levels of ^
that is not deleted by Mls-1a. The implications of this latter
subset for T cell repertoire selection and lineage commitment
will be discussed.
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Methods
Animals
Congenic BALB.D2.Mls3 (H-^ , Mls-1a) mice were maintained
from.breeding pairs kindly provided by Dr. H Festenstein (12).
BALB/c nude mice and C57BL/6 nude mice were supplied by
BOM (Denmark). TCRa/3 transgenic mice were as described (7).
Severe combined immunodeficiency (SCID) mice on a H-2"
(BALB/c) background were supplied by Iffa Credo. F, and F2
hybrids were bred locally.
mAbs and FACS analysis
Cytotoxic rat IgM mAbs against CD8 (3.168.1) and against
Thy-1 (AT83) were used in the presence of rabbit complement
to deplete thymocytes of CD8+ cells prior to sorting for
CD4 SP thymocytes and to deplete spleen cell suspensions of
T cells respectively.
For three-colour immunofluorescence, aliquots of thymocytes
or lymph node (LN) cells were stained at 4°C with rat mAbs
KJ16 133 (anti-Vp8.1/8.2; ref. 13), 17A2 (anti-CD3; ref. 14), or
B20.1 (anti-V.,2; B. Malissen, unpublished data), followed by a
FITC-conjugated goat anti-rat second reagent. An additional
incubation with phycoerythrin (PE)-conjugated anti-CD4 and
biotinylated anti-CD8 (Becton-Dickinson) was followed by
avidin-TANDEM (Southern Biotechnology). Samples were
analysed on a FACScan (Becton-Dickinson). Fluorescent
histograms for Vfl, Va, or CD3 staining were obtained after
gating on thymocyte subpopulations defined by CD4 and CD8
staining. In all cases representative histograms are shown from
an analysis of at least four mice. Only data of viable cells were
collected, using a live gate by a combination of forward and
90° light scatter.
Cell Culture
All cell culture was carried out in Dulbecco's modified
Eagle's medium supplemented with 5% FBS and 5 x 10~5 M
2-mercaptoethanol. Sorted CD4 SP thymocytes were cultured
for 20 or 40 h at a concentration of 1.5 x 108 cells/ml in
250 /tl medium.
Hydrocortisone injection
Two week old mice were injected i.p. with 150 /il hydrocortisone
acetate suspension at 25 mg/ml (Steuli & Co., Switzerland) and
killed 2 days later. Six week old mice were injected i.p. with 250 /J
suspension and were killed at 2, 5, 6, and 7 days after injection.
IL-2 and IFN-y production
Responder cells from LN were cultured at 2 x 108 cells/ml
in 2 ml in 24-well plates. Cultures were stimulated with 4.5 x
108 T cell depleted irradiated (1000 rad) spleen cells from
BALB.D2.Mls8 or BALB/c mice. Supernatants were collected
after 72 h for anaJysis of their IL-2 or IFN-y content.
IL-2 assay
IL-2 levels were determined using an IL-2-dependent (IL-4
non-responsive) subline of CTLL-2 and a colorimetric assay
based on the production of hexosaminidase. Units per millilitre
of sample were calculated by comparing titrations of test samples
with a standard curve of human recombinant IL-2.
IFN-y assay
IFN-7 levels were determined using an ELISA assay (15). The
rat mAb R4-6A2 was used as the coating antibody and the mAb
AN-18.17.24 was used as the detecting antibody. Horseradish
peroxidase labelled streptavidin-biotin complex (BRL,
Gaithersburg, MD) was used to detect binding of biotin-labelled
AN-18.17 24 to IFN-7. Recombinant mouse IFN-7 was used
as a standard.
Injection of nude mice
Five week old nude mice were injected i.v. with 5 x 105
CD4 SP thymocytes in 250/J PBS, prepared from 1 month
old BALB.D2.Mlsa TCR transgenic mice by antibody and
complement deletion of CD8+ cells followed by sorting for
CD4+ cells on a FACS. Nude mice were killed 6 weeks after
injection and LN cell suspensions were analysed for TCR
expression by three-colour flow cytometry as described above.
Results
Two subsets of CD4 SP thymocytes in TCR transgenic mice
Three-colour immunofluorescence revealed two distinct
populations of CD4 SP thymocytes in 2 week old BALB/c
transgenic mice (non-selective background) that differed in CD3
and 0T density (Figs 1 and 2). Of the CD4 SP cells, 50% were
00310-,*** and 45% were COS/p-,*™. In the CD8 SP subset
80 - 90% of cells were CD3//3Thi°tl and the remainder CD3/JV"-
The proportion of CD3/j3Tlow cells in both SP subsets decreased
with age (data not shown; see aJso Fig. 5). Expression of aT was
very low on most SP thymocytes (Fig. 2).
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Fig. 1 . Thymus subsets of TCR transgenic mice. Control or
hydrocortisone (HC) resistant thymocytes from 2 week old TCR transgenic
mice on a BALB/c or BALB.D2.Mls8 background were stained with
mAbs directed against CD4 and CD8, and analysed by flow cytometry.
The average cellularity of the thymuses were 1.7 x 108 (BALB/c),
1.7 x 108(BALB.D2.Mlsa), 5.6 x 106 (BALB/c + HC), and 4.2 x 10*
(BALB.D2MIS8 + HC).
Deletion of 003/0^ SP thymocytes in the presence of Mis-1"
The C03lpJh& cells in both CD4 and CD8 SP thymocyte
populations were deleted when the BALB/c transgenic mice
were crossed with BALB.D2.Mls", whereas the CDS//?/*" SP
thymocytes were not deleted (Fig. 2).
Hydrocortisone sensitivity of 003/0-1°" SP thymocytes
All CD3low SP thymocytes were cortisone sensitive and those SP
thymocytes remaining after cortisone treatment of BALB/c
transgenic mice expressed high levels of both /3j and CD3 (Fig.
3). In contrast, most of the cortisone resistant SP thymocytes
expressed low to intermediate levels of aT and < 10% stained
brightly with the antibody against \Jl (Fig. 3). Assuming that
each TCR /3-chain and CD3 molecule must be associated with
an a-chain, it follows that at least 90% of the cortisone resistant
SP thymocytes in these mice expressed two a-chains on their
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cell surface: low to intermediate levels of the transgenic a-chain
in addition to high levels of an endogenously rearranged
o-chain(s). The presence of two a-chains on the cell surface of
hybridomas derived from T cell clones from TCR transgenic mice
has previously been demonstrated by immunoprecipitatjon (9).
When cortisone was administered to the Mls-1a transgenic
mice all remaining cells were CD3hi°h but there were few CD4
SP cells which stained brightly with the antibodies against the
transgenic a- or /3-chains (Fig. 3). These few bright CD4 SP cells
(10-15%) might in fact express endogenously rearranged Vg8
or V ^ genes recognized by the same antibodies, since CD4 SP
thymocytes from non-transgenic littermates expressed V^8 and
V.,2 at similar levels (data not shown). The greater proportion of
Vptf^ cells remaining in the CD8 SP population after cortisone
treatment may reflect the tendency of cells expressing this Vp8
gene segment to be positively selected towards the CD8 lineage
(11).
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Rg. 2. Expression of transgenic TCRa and TCR0 chain and CD3 by SP thymus subsets Thymocytes from 2 week old TCR transgenic BALB/c or
BALB.D2.Mtea mice were triple stained with mAbs against CD4, CD8, and either TCRa chain, TCR/3 chain, or CD3. Data shown are gated for
CD4+CD8" or CD4-CD8+ subsets (see Fig. 1).
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Fig. 3. Expression of transgenic TCRa and TCR0 chain and CD3 by SP thymus subsets of hydrocortisone-treated TCR transgenic mice on a BALB/c
or BALB.D2.Mis8 background. Thymocytes were stained and gated as described in Fig 2
CD3°" CD4 SP cells are a post-DP stage of development
The cortisone sensitivity of the CDS**" CD4 SP cells led us to ask
if these cells in fact represented a pre-DP stage of development
(16,17), which expressed the transgenic TCR abnormally early.
Three pieces of evidence suggested that this was not the case.
First, when sorted CD4 SP thymocytes from a BALB.D2.Mls8
transgenic mouse were cultured for 20 or 40 h no differentiation
into DP thymocytes was observed (data not shown). Second, no
CD310" CD4 SP thymocytes were found in 2 week old H-2d
SCID-TCR transgenic mice (Fig. 4) and if such cells were pre-DP
and hence not dependent on positive selection there is no a priori
reason why they should be absent from such mice. Third, we
compared the kinetics of regeneration of thymocyte populations
after cortisone treatment of adult BALB/c transgenic mice (Fig.
5). Two days after cortisone treatment only CD3//STh"°h SP and
DP cells were present. By day 5, however, the majority of DP
thymocytes expressed low levels of TCR, as did 15% of CD8
SP, but the CD4 SP cells were still CD3hiflt1. By the seventh day
after treatment a CDS10" CD4 SP population was clearly visible
and TCR expression in the DP thymocytes had returned to the
usual distribution, with - 1 5 % CD3//3Th«h. Thus, CD310* DP cells
reappeared well before the CDS10" CD4 SP cells, suggesting
that the CD310* CD4 SP cells were not at a pre-DP stage of
development.
Deletion of Mls-1" can occur when thymocytes are DP
Between 10 and 15% of DP thymocytes of all BALB/c transgenic
mice examined were CD3//J/11*1 and aj10", suggesting that they
expressed endogenously rearranged or-chains on their cell
surfaces. These cells were nearly all deleted in the presence of
Mls-1a (Fig. 6) and a proportion were cortisone resistant (Fig. 5).
TCR expression in LN T cells of transgenic mice
In an attempt to assess the developmental potential of the
CD310" SP thymocytes, we next examined TCR expression in
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Fig. 4. Expression of transgenic TCRa (shaded) and 0 (open) chains and CD3 by DP thymocytes from SCID mice on a BALB/c background.
Thymocytes from 2 week old TCR transgenic SCID mice were triple stained with mAbs against CD4, CD8, and TCR (a, /3, or CD3). The upper panels
are gated on the DP subset.
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Fig. 5. Expression of CD3 by SP and DP thymocytes of control or hydrocortsone-treated TCR transgenjc BALB/c mice (2, 5, 6, and 7 days after
cortisone treatment). Thymocytes from adult (6 week old) mice were triple stained with mAbs against CD4, CD8, and CD3, and data are shown
gated for CD4+CD8", CD4-CD8+, and CD4+CD8+ subsets
158 Timing of positive and negative selection
CD4*8+
m
8
oI
CD3
Log TCR fluorescence
Fig. 6. Expression of transgenic TCRa and TCR0 chain and CD3 by
DP thymocytes from BALB.D2.Mls3 (shaded) and BALB/c (open) mice,
stained as in Fig. 2 The proportion of cells with high transgenic 0-chain
expression was 13% in BALB/c mice and 1.5% in BALB.D2 Mis8 mce.
LN T cells of adult Mls-1a transgenic mice and control BALB/c
transgenic mice (Fig. 7). Surprisingly, in the Mls-1a transgenic
mice, 55% of CD4 + and 85% of CD8+ LN T cells expressed
high levels of /3T. As expected, aT expression was low on most
of these cells (Fig. 7) and CD3 expression was homogeneously
high. The ratio of CD4:CD8 in BALB.D2.Mlsa LN T cells was
1:3.5 (compared to 1.8:1 in control BALB/c). Despite expression
of high levels of /3T, LN T cells from the Mls-1a transgenic mice
were non-responsive to Mls-1a, as assessed by their abilities to
proliferate and to produce both IFN-7 and IL-2 (Table 1). Thus
it is possible that these CD3//3ThiB'1 SP cells in LN were derived
from CDSIfi-^ SP cells that escaped deletion in the Mls-1a
thymus and subsequently upregulated their TCR in the periphery.
Transfer of CD30" CD4 SP thymocytes to nude mice
More direct evidence that CDS'0" CD4 SP thymocytes were not
just a dead-end lineage, but were capable of some maturation
outside the thymus, was obtained from experiments in which
sorted CD4 SP thymocytes from Mls-1a transgenic mice were
transferred into C57BL/6 (H^") nude mice or BALB/c (H-2")
nude mice. Six weeks after i.v. injection of 5 x 105 cells, the
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Fig. 7. Expression of transgenic TCRa and TCR/3 chain by CD4+ and CD8+ T ceOs from LN of BALB.D2.Mls8 and BALB/c mice. Lymphocytes
were triple stained as in Fig. 2 and data are shown gated for CD4+ or CD8+ populations. All CD4+ and CD8+ T cells were CDS*0*1 (not shown).
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mice were killed and LN cells were analysed for transgenic
TCR expression. On average 9.8 x 106 ( ±6 x 10s) cells
were recovered from the C57BL/6 nude mice and 2.9 x 107
(± 4 x 10s) cells were recovered from the BALB/c nude mice,
as opposed to 6 x 106 and 5 x 106 from the respective
non-injected control mice. Double staining with antibodies against
Thy-1 and H-2Kb indicated that in the C57BL76 nude mice at
most 6% of T cells were of transgenic origin. About 5% of the
recovered T cells expressed low levels of aT and /3j, and there
were few CDS** cells. In the BALB/c nude mice, however,
half of CD4+ T cells expressed high levels of CD3 and the
remainder were CDS'01" (Fig. 8). The /3T expression followed a
similar pattern, with 40% high and 50% low. Approximately 80%
of these cells expressed low levels of aT. In contrast CD4~CD8~
cells in the injected BALB/c nude LNs were negative for staining
with V^8 and VJ> specific mAbs (data not shown). Furthermore,
no significant V ^ or V ^ staining was seen in CD4+ LN cells
from age-matched control (uninjected) BALB/c nude mice. Given
these data, it seems reasonable to conclude that the CD4+ T
cells recovered after transfer were of transgenic donor origin,
despite the absence of a strain specific marker.
cells to identify a CD4 SP thymocyte subset that expresses low
levels of CD3 (see below).
The timing of intrathymic deletion by Mls-1a has been a
subject of some controversy. In this regard, recent studies from
two groups (22,23) have shown that DP V/0**> cells are deleted
in the thymus of normal Mls-1a bearing mice, whereas DP V^o*"*
cells are unaffected, thus arguing in favour of deletion occurring
at a late DP stage. On the other hand, Guidos etal. (21) have
identified CD4 SP thymocytes with a V|36low phenotype that are
not deleted in Mls-1a mice following intrathymic transfer of DP
blasts, and Schneider etal. (24) have found cells with a similar
phenotype (V^10" CD4 SP) in the early post-natal Mls-1a
thymus. In both instances V^"0*1 CD4 SP thymocytes were
deleted by Mls-1a, supporting models in which Mls-1a deletion
occurs at a SP stage. In transgenic models, Pircherera/. (7,11)
observed significant deletion of CD3/Vs8.1hioh T cells by Mls-1a
in the thymus and periphery of both /S and a/3 transgenic mice
on a positively selecting (H-2Wd) background; however, these
cells were not further analysed for CD4/CD8 phenotype. In con-
Dlscusslon
The data presented here demonstrate that two subsets of CD4
SP thymocytes can be clearly distinguished in TCRa$ transgenic
mice in the absence of the appropriate positively selecting MHC
restriction element. Comparison of staining patterns of mAbs
directed against the transgenic a- or /3-chains with CD3 indicated
that one subset expresses CD3 and /3T at high levels (paired
with a putative endogenous a-chain) while the other subset
expresses low levels of CD3 and /3T. The CD3I&J"*" CD4 SP
subset is completely deleted in the thymus of mice expressing
Mls-1a but is not sensitive to in vivo cortisone treatment.
Reciprocally the 0031^*°™ subset resists deletion by Mls-1a but
is ablated by cortisone.
The relationship of these CD4 SP subsets to those defined
so far in normal mice is not clear. Normal CD4 SP thymocytes
are heterogeneous with respect to expression of a number of
phenotypic markers (reviewed in ref. 18) but are generally
considered to be homogeneously CD3h<Btl and cortisone
resistant. Nevertheless several studies have documented a partial
sensitivity of CD4 SP thymocytes to hydrocortsone in vivo (19,20).
Of particular relevance to the data presented here, Guidos et at.
(21) have recently used intrathymic transfer of purified DP blast
Table 1. LN T cells from TCR transgenic BALB.D2.Mis3 mice
are non-responsive to Mls-1a in vitro
Responding LN
cells
BALB/c
BALB.D2 Mis8
IL-2 (U/ml) IFN-7 (U/ml)
BALB.D2.Mls8 BALB/c BALB.D2.Mls3 BALB/c
42.8 ± 6.7
0.4 ± 0.2
3 9 . 6 ± 5 4
LN cells from 6 week old TCR transgenic mice on a BALB/c or
BALB.D2.Mlsa background were cultured with irradiated T cell depleted
spleen cells from normal BALB/c or BALB.D2.Mls8 mice. After 48 h
supernatants (SNS) were collected and assayed for IL-2 or IFN-y. Data
are presented as mean ± SD of four individual mice.
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Fig. 8. (A) Expression of CD4 and CDS by LN cells from BALB/c nude
mice 6 weeks after injection with CD310" CD4 SP thymocytes from
BALB.D2.Mls8 TCR transgenic mice. (B) Expression of transgenic TCRa
and TCR/3 chain and CD3 by CD4+CD8" cells as above. Cells were
triple stained as in Rg. 2 and data are shown gated for CD4+CD8".
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trast, Blackman et al. (25) found little evidence for clonal deletion
by Mls-1a in an independent V^8.1 transgenic model. The
present data confirm and extend these previous reports by
demonstrating that 00310^ (but not CD3//SV0") cells are
deleted by Mls-1a irrespective of their DP or SP phenotype. We
therefore favour the hypothesis that clonal deletion by self
superantigens such as Mls-1a occurs at a stage of thymic
development corresponding to the acquisition of
high TCR density.
Although CD3//3Ttu°h SP cells were not detectable in the
thymus of BALB.D2.Mlsa mice such cells accounted for the
majority of both CD4 SP and CD8 SP subsets in the periphery.
Nevertheless no specific response of these CD3/0Th"oh cells to
Mls-1a (assessed by proliferation or lymphokine production)
could be detected in \ntro. These findings are reminiscent of other
recent reports in which encounter of T cells with Mls-1a, either
in the thymus or periphery, was found to result in subsequent
functional non-responsiveness (25-27). In the present case
lack of Mls-1a responsiveness could reflect either anergy or
functional immaturity of the CD3//3Thl0h population.
An interesting property of CD3//3Ttow CD4 SP thymocytes was
their ability to partially reconstitute young athymic mice upon i.v.
transfer. Previous studies have shown that mature peripheral T
cells are capable of extensive proliferation in syngeneic athymic
mice, ultimately accounting for 10 -15% of total cells in spleen
or LN (28). In the present study, 13% (~4 x 106) of recovered
nude LN cells were CD4 SP following transfer of 5 x 105
00310/™ BALB.D2.Mlsa CD4 SP thymocytes to congenic
BALB/c nude mice, indicating that considerable expansion of
the inoculum had occurred. About 50% of the recovered CD4
SP cells were CD3//9Thl0h and the remainder were CD3//V".
Thus it is clear that at least some cells with a CD3//3V0* CD4 SP
phenotype are capable of survival (and expansion) in the
periphery. Furthermore it seems likely that CDSIP^W CD4 SP
cells are derived from these 00310^ CD4 SP cells via TCR
upregulation (although it cannot be formally excluded that these
cells arise from rare CD3//SThiotl cells that escape deletion in the
Mls-1a thymus). It is worth noting that the failure of CD3//3V0"
CD4 SP thymocytes to survive upon transfer to C57BL/6 (H-2°)
nude mice raises the possibility that these cells had already
become restricted to H-2d (presumably class II MHC) molecules
in the BALB.D2.Mls8 thymus. However, other interpretations of
these data (including peripheral clonal deletion upon exposure
to the H-2Db restriction element) remain tenable.
If CD3//ST10" CD4 SP thymocytes are in fact positively selected
(as suggested by their CD4 SP phenotype and ability to expand
in a H-2? environment), it would follow that these cells represent
a stage of thymic development that has undergone positive but
not negative selection events. A similar 'transitional phenotype'
has been noted by Guidos etal. (21) for CD310" CD4 SP
thymocytes developing in normal mice shortly after intrathymic
transfer of DP blasts. In contrast, Benoist and Mathis (29) could
not find any evidence for positive selection (assessed by V,,
usage) among CD310" CD4 SP thymocytes in normal mice,
although positive selection was evident in the CDS"*1 CD4 SP
subset. Our own previous studies in normal mice (6) could not
directly address this issue since we only looked for positive
selection among the CDS*"0*1 cortisone-resistant thymocyte
population.
Finally, it should be noted that the identification of CDS10" and
of CD4 SP thymocytes has implications for
lineage models of thymocyte development. Current evidence
from a variety of sources favours the hypothesis that CD4 SP
and CD8 SP thymocytes are derived from a common DP
precursor (reviewed in ref. 18). Within the framework of such a
model, two (non-mutually exclusive) alternative pathways of
thymic development can be envisaged to explain our data.
Assuming that TCR upregulation is irreversible during develop-
ment, fully mature CDS'**1 SP thymocytes could be derived from
CDS'0" DP precursors via either C D S ^ DP or CD310" SP
intermediates. The coexistence of both pathways would suggest
that positive selection (as manifested by DP — SP transition) does
not necessarily require concomitant upregulation of surface TCR
expression and that the latter phenomenon may occur as a rather
late event in T cell development.
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